BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34883111)

  • 1. Role of Mel1/Prdm16 in bone differentiation and morphology.
    Kaneda-Nakashima K; Igawa K; Suwanruengsri M; Naoyuki F; Ichikawa T; Funamoto T; Kurogi S; Sekimoto T; Yamashita Y; Chosa E; Yamaguchi R; Morishita K
    Exp Cell Res; 2022 Jan; 410(2):112969. PubMed ID: 34883111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation.
    Nishikata I; Sasaki H; Iga M; Tateno Y; Imayoshi S; Asou N; Nakamura T; Morishita K
    Blood; 2003 Nov; 102(9):3323-32. PubMed ID: 12816872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.
    Mochizuki N; Shimizu S; Nagasawa T; Tanaka H; Taniwaki M; Yokota J; Morishita K
    Blood; 2000 Nov; 96(9):3209-14. PubMed ID: 11050005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation.
    Matsubara T; Kida K; Yamaguchi A; Hata K; Ichida F; Meguro H; Aburatani H; Nishimura R; Yoneda T
    J Biol Chem; 2008 Oct; 283(43):29119-25. PubMed ID: 18703512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 enhancer-binding protein 3 is essential for the expression of asparagine-linked glycosylation 2 in the regulation of osteoblast and chondrocyte differentiation.
    Imamura K; Maeda S; Kawamura I; Matsuyama K; Shinohara N; Yahiro Y; Nagano S; Setoguchi T; Yokouchi M; Ishidou Y; Komiya S
    J Biol Chem; 2014 Apr; 289(14):9865-79. PubMed ID: 24563464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; Löwenberg B; Delwel R
    Exp Hematol; 2003 Nov; 31(11):1066-72. PubMed ID: 14585371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects.
    Maeno T; Moriishi T; Yoshida CA; Komori H; Kanatani N; Izumi S; Takaoka K; Komori T
    Bone; 2011 Oct; 49(4):673-82. PubMed ID: 21807129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo.
    Wu M; Hesse E; Morvan F; Zhang JP; Correa D; Rowe GC; Kiviranta R; Neff L; Philbrick WM; Horne WC; Baron R
    Bone; 2009 Apr; 44(4):528-36. PubMed ID: 19095088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway.
    Qiu WX; Ma XL; Lin X; Zhao F; Li DJ; Chen ZH; Zhang KW; Zhang R; Wang P; Xiao YY; Miao ZP; Dang K; Wu XY; Qian AR
    J Cell Mol Med; 2020 Jan; 24(1):317-327. PubMed ID: 31709715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
    Young DW; Pratap J; Javed A; Weiner B; Ohkawa Y; van Wijnen A; Montecino M; Stein GS; Stein JL; Imbalzano AN; Lian JB
    J Cell Biochem; 2005 Mar; 94(4):720-30. PubMed ID: 15565649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated osterix expression elicited by Runx2 and Dlx5 is required for the accelerated osteoblast differentiation in PP2A Cα-knockdown cells.
    Yang D; Okamura H; Qiu L
    Cell Biol Int; 2018 Apr; 42(4):403-410. PubMed ID: 29068100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein rescues the lack of secondary cartilage in Runx2-deficient mice.
    Fukuoka H; Shibata S; Suda N; Yamashita Y; Komori T
    J Anat; 2007 Jul; 211(1):8-15. PubMed ID: 17555546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
    Lahortiga I; Agirre X; Belloni E; Vázquez I; Larrayoz MJ; Gasparini P; Lo Coco F; Pelicci PG; Calasanz MJ; Odero MD
    Oncogene; 2004 Jan; 23(1):311-6. PubMed ID: 14712237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
    Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
    Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible roles of Runx1 and Sox9 in incipient intramembranous ossification.
    Yamashiro T; Wang XP; Li Z; Oya S; Aberg T; Fukunaga T; Kamioka H; Speck NA; Takano-Yamamoto T; Thesleff I
    J Bone Miner Res; 2004 Oct; 19(10):1671-7. PubMed ID: 15355562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requisite roles of Runx2 and Cbfb in skeletal development.
    Komori T
    J Bone Miner Metab; 2003; 21(4):193-7. PubMed ID: 12811622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx2, a multifunctional transcription factor in skeletal development.
    Komori T
    J Cell Biochem; 2002; 87(1):1-8. PubMed ID: 12210716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.
    Hesse E; Saito H; Kiviranta R; Correa D; Yamana K; Neff L; Toben D; Duda G; Atfi A; Geoffroy V; Horne WC; Baron R
    J Cell Biol; 2010 Dec; 191(7):1271-83. PubMed ID: 21173110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.